{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:55:34Z","timestamp":1781636134284,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005296","name":"Universit\u00e4tsklinikum Regensburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005296","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This retrospective cohort study utilizes a nationwide database to provide information about the epidemiology and surgical treatment practices of peritoneal mesothelioma in Germany over the years 2019 to 2024.<\/jats:p>\n                  <jats:p>Data collected by the German Institute for the Hospital Remuneration System (InEK) was examined by age, sex, treatment with HIPEC, PIPAC, or peritonectomy, ICU stay, type of hospital, and duration of stay. Additionally, the Patient Clinical Complexity Level (PCCL) - ranging from 0 to 6 - was analyzed.<\/jats:p>\n                  <jats:p>In total 3394 patients with peritoneal mesothelioma were recorded during the years 2019 to 2024 in Germany, with an average annual incidence of 0.68 per 100,000 inhabitants. The mean duration of hospital stay was 9 days. The median PCCL was 1. The median patient age group was 65 to 74. 16% of patients had an ICU stay. Most patients were treated at maximum care hospitals with over 1000 beds. Only 9% of patients received HIPEC treatment. 15% received some form of peritonectomy. PIPAC was performed on only 5% of the patients. In total, considering that patients can be coded with multiple procedures, 20% of all patients received surgical therapy.<\/jats:p>\n                  <jats:p>It was demonstrated that only a small percentage of patients received HIPEC, CRS, or PIPAC. This shows a grave discrepancy between guideline-recommendations and actual clinical practice. Potential reasons could be a lack of consideration of these procedures or misleading economic incentives. Ultimately, the findings highlight the need for increased awareness of peritoneal mesothelioma and underscore the importance to address the aforementioned observed discrepancy.<\/jats:p>","DOI":"10.1186\/s12957-026-04209-6","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T08:55:00Z","timestamp":1771404900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Underutilization of CRS, HIPEC &amp; PIPAC in peritoneal mesothelioma across a German nationwide cohort"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7920-3055","authenticated-orcid":false,"given":"Veronika","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Hornung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans J\u00fcrgen","family":"Schlitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miklos","family":"Acs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"4209_CR1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-025-17358-x","author":"LM Brown","year":"2025","unstructured":"Brown LM, Wilkins SG, Bansal VV, Su DG, Gomez-Mayorga J, Turaga KK, et al. Consensus guideline for the management of peritoneal mesothelioma. Annals Surg Oncol. 2025. https:\/\/doi.org\/10.1245\/s10434-025-17358-x.","journal-title":"Annals Surg Oncol"},{"key":"4209_CR2","unstructured":"Rau B, K\u00f6hler F, Bachleitner-Hoffmann T, Hacker U, Lehmann K, Piso P et al. Peritoneales Mesotheliom und Pseudomyxoma peritonei. Deutsche Gesellschaft f\u00fcr H\u00e4matologie und Medizinische Onkologie (DGHO); 2025; https:\/\/www.onkopedia.com\/de\/onkopedia\/guidelines\/peritoneales-mesotheliom-und-pseudomyxoma-peritonei\/@@guideline\/html\/index.html"},{"key":"4209_CR3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ejso.2020.02.011","volume":"47","author":"S Kusamura","year":"2021","unstructured":"Kusamura S, Kepenekian V, Villeneuve L, Lurvink RJ, Govaerts K, De Hingh IHJT, et al. Peritoneal mesothelioma: PSOGI\/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Eur J Surg Oncol. 2021;47:36\u201359. https:\/\/doi.org\/10.1016\/j.ejso.2020.02.011.","journal-title":"Eur J Surg Oncol"},{"key":"4209_CR4","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1111\/pin.13006","volume":"70","author":"D Mori","year":"2020","unstructured":"Mori D, Kido S, Hiraki M, Sumi K, Ureshino N, Masuda M, et al. Peritoneal adenomatoid (microcystic) mesothelioma. Pathol Int. 2020;70:876\u201380. https:\/\/doi.org\/10.1111\/pin.13006.","journal-title":"Pathol Int"},{"key":"4209_CR5","doi-asserted-by":"publisher","first-page":"100737","DOI":"10.1016\/j.currproblcancer.2021.100737","volume":"45","author":"MD Ray","year":"2021","unstructured":"Ray MD, Dhall K. Hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of peritoneal surface malignancies \u2013 An evidence-based review. Curr Probl Cancer. 2021;45:100737. https:\/\/doi.org\/10.1016\/j.currproblcancer.2021.100737.","journal-title":"Curr Probl Cancer"},{"key":"4209_CR6","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.jtho.2021.12.014","volume":"17","author":"JL Sauter","year":"2022","unstructured":"Sauter JL, Dacic S, Galateau-Salle F, Attanoos RL, Butnor KJ, Churg A, et al. The 2021 WHO classification of tumors of the pleura: advances since the 2015 classification. J Thorac Oncol Elsevier. 2022;17:608\u201322. https:\/\/doi.org\/10.1016\/j.jtho.2021.12.014.","journal-title":"J Thorac Oncol Elsevier"},{"key":"4209_CR7","doi-asserted-by":"publisher","unstructured":"Ettinger DS, Wood DE, Stevenson J, Aisner DL, Akerley W, Bauman JR et al. Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. Huntington NY, USA: National Comprehensive Cancer Network; 2023;21:961\u201379. https:\/\/doi.org\/10.6004\/jnccn.2023.0045.","DOI":"10.6004\/jnccn.2023.0045"},{"key":"4209_CR8","doi-asserted-by":"publisher","unstructured":"Cort\u00e9s-Guiral D, Kranenburg O, Sgarbura O, Van Der Speeten K, Taibi A, H\u00fcbner M et al. PIPAC Pharmacologic and Clinical Data. Journal of Surgical Oncology. John Wiley & Sons, Ltd; 2024;130:1337\u201348. https:\/\/doi.org\/10.1002\/jso.27900.","DOI":"10.1002\/jso.27900"},{"key":"4209_CR9","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1245\/s10434-021-11316-z","volume":"29","author":"J-F Zhang","year":"2022","unstructured":"Zhang J-F, Lv L, Zhao S, Zhou Q, Jiang C-G. Hyperthermic intraperitoneal chemotherapy (HIPEC) combined with surgery: A 12-Year Meta-Analysis of this promising treatment strategy for advanced gastric cancer at different stages. Ann Surg Oncol. 2022;29:3170\u201386. https:\/\/doi.org\/10.1245\/s10434-021-11316-z.","journal-title":"Ann Surg Oncol"},{"key":"4209_CR10","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1002\/jso.26894","volume":"125","author":"H Khan","year":"2022","unstructured":"Khan H, Johnston FM. Current role for cytoreduction and HIPEC for gastric cancer with peritoneal disease. J Surg Oncol. 2022;125:1176\u201382. https:\/\/doi.org\/10.1002\/jso.26894.","journal-title":"J Surg Oncol"},{"key":"4209_CR11","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1002\/cncr.32870","volume":"126","author":"CCW Group","year":"2020","unstructured":"Group CCW. The Chicago consensus on peritoneal surface malignancies: management of peritoneal mesothelioma. Cancer. 2020;126:2547\u201352. https:\/\/doi.org\/10.1002\/cncr.32870.","journal-title":"Cancer"},{"key":"4209_CR12","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/jso.27885","volume":"130","author":"S Kusamura","year":"2024","unstructured":"Kusamura S, Bhatt A, van Der Speeten K, Kepenekian V, H\u00fcbner M, Eveno C, et al. Review of 2022 PSOGI\/RENAPE consensus on HIPEC. J Surg Oncol. 2024;130:1290\u20138. https:\/\/doi.org\/10.1002\/jso.27885.","journal-title":"J Surg Oncol"},{"key":"4209_CR13","doi-asserted-by":"publisher","unstructured":"Cashin PH, Jansson Palmer G, Asplund D, Graf W, Syk I. Peritoneal mesothelioma in Sweden: A population-based study. Cancer Medicine. John Wiley & Sons, Ltd; 2019;8:6468\u201375. https:\/\/doi.org\/10.1002\/cam4.2436.","DOI":"10.1002\/cam4.2436"},{"key":"4209_CR14","doi-asserted-by":"publisher","unstructured":"Steadman JA, Grotz TE. Principles of Surgical Management of Peritoneal Mesothelioma. Journal of the National Comprehensive Cancer Network. Huntington NY, USA: National Comprehensive Cancer Network; 2023;21:981\u20136. https:\/\/doi.org\/10.6004\/jnccn.2023.7055.","DOI":"10.6004\/jnccn.2023.7055"},{"key":"4209_CR15","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.annpat.2024.05.003","volume":"44","author":"L Villeneuve","year":"2024","unstructured":"Villeneuve L, Odin C, Bonnefoy I, Pichon P, Valmary-Degano S, Bibeau F, et al. R\u00e9seau RENAPE: vers Une meilleure \u00e9quit\u00e9 d\u2019acc\u00e8s aux Soins et \u00e0 l\u2019expertise pour les patients Atteints de cancers rares du p\u00e9ritoine. Ann Pathol. 2024;44:291\u20135. https:\/\/doi.org\/10.1016\/j.annpat.2024.05.003.","journal-title":"Ann Pathol"},{"key":"4209_CR16","unstructured":"Accueil [Internet]. Renape. [cited 2026 Jan 3]. https:\/\/www.renape-online.fr\/. Accessed 3 Jan 2026."},{"key":"4209_CR17","doi-asserted-by":"publisher","first-page":"e186847","DOI":"10.1001\/jamanetworkopen.2018.6847","volume":"2","author":"JM Foster","year":"2019","unstructured":"Foster JM, Sleightholm R, Patel A, Shostrom V, Hall B, Neilsen B, et al. Morbidity and mortality rates following cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy compared with other High-Risk surgical oncology procedures. JAMA Netw Open. 2019;2:e186847\u2013186847. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.6847.","journal-title":"JAMA Netw Open"},{"key":"4209_CR18","doi-asserted-by":"publisher","unstructured":"Daniel SK, Sun BJ, Lee B. PIPAC for Gastrointestinal malignancies. J Clin Med Switz. 2023;12. https:\/\/doi.org\/10.3390\/jcm12216799.","DOI":"10.3390\/jcm12216799"},{"key":"4209_CR19","doi-asserted-by":"publisher","unstructured":"Di Giorgio A, Macr\u00ec A, Ferracci F, Robella M, Visaloco M, De Manzoni G et al. 10 Years of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): A Systematic Review and Meta-Analysis. Cancers (Basel). Switzerland; 2023;15. https:\/\/doi.org\/10.3390\/cancers15041125.","DOI":"10.3390\/cancers15041125"},{"key":"4209_CR20","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00104-025-02246-7","volume":"96","author":"C Yurttas","year":"2025","unstructured":"Yurttas C, Kalmbach S, Ansorge E, Bezmawi M, Blumenstock G, L\u00f6ffler MW, et al. Ist die zytoreduktive chirurgie Mit HIPEC ausreichend finanziert? Die Chirurgie. 2025;96:951\u20139. https:\/\/doi.org\/10.1007\/s00104-025-02246-7.","journal-title":"Die Chirurgie"},{"key":"4209_CR21","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/codi.12975","volume":"17","author":"B Moran","year":"2015","unstructured":"Moran B, Cecil T, Chandrakumaran K, Arnold S, Mohamed F, Venkatasubramaniam A. The results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1200 patients with peritoneal malignancy. Colorectal Dis. 2015;17:772\u20138. https:\/\/doi.org\/10.1111\/codi.12975.","journal-title":"Colorectal Dis"},{"key":"4209_CR22","doi-asserted-by":"publisher","unstructured":"Calthorpe L, Romero-Hernandez F, Miller P, Conroy PC, Hirose K, Kim A, et al. Contemporary trends in malignant peritoneal mesothelioma: incidence and survival in the united States. Cancers. 2023;15. https:\/\/doi.org\/10.3390\/cancers15010229.","DOI":"10.3390\/cancers15010229"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04209-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04209-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04209-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:24:57Z","timestamp":1781634297000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04209-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4209"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04209-6","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. Patient data was retrieved from InEK, a nationwide database freely accessible for medical research purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. Patient data was retrieved from InEK, a nationwide database freely accessible for medical research purposes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"97"}}